Send Message

Rapid Response Amphetamine (AMP) Rapid Test Kit Drug of Abuse

Basic Information
Place of Origin: China
Brand Name: Dewei
Certification: ISO, CE, FDA
Model Number: DWX-DOA
Minimum Order Quantity: 5000 units
Price: Negotiable
Packaging Details: 25test/box
Delivery Time: in 20 days
Payment Terms: T/T, Western Union, L/C
Supply Ability: 500,000pcs/day
Detail Information
Sample: Urine Certificate: ISO, CE, FDA
Type: Cassette Or Strip Origin: China
Shelf Life: 24 Months Usage: Professional Or Self Test
High Light:

mindray chemistry reagents


chemistry analyzer reagents

Product Description

Rapid Response Amphetamine (AMP) Rapid Test


Amphetamine (AMP) Rapid Test is a rapid, screening test for the qualitative detection of Amphetamine and metabolites in human urine at specified cut off levels.

For professional use only.

For in vitro diagnostic use only.



Rapid Amphetamine (AMP) Test is an immuno-chromatographic assay for the qualitative determination of the presence of Amphetamine (AMP) listed in the table below.

Drug(Identifier) Calibrator Cut-off level
Amphetamine (AMP) d-Amphetamine 1000ng/mL


This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to Amphetamine (AMP) of abuse test result, particularly when preliminary positive results are indicated.



Amphetamine and the structurally related “designer” drugs are sympathomimetic amines whose biological effects include potent central nervous system (CNS) stimulation, anorectic, hyperthemic , and cardiovascular properties. They are usually taken orally, intraveneously, or by smoking. Amphetamines are readily absorbed from the gastrointestinal tract and are then either deactivated by the liver or excreted unchanged in the urine with a half life of about 12 hours. It can be detected in the urine for 1 to 2 days after use. Amphetamine is metabolized to deaminated (hippuric and benzoic acids) and hydroxylated metabolites. Methamphetamine is partially metabolized to amphetamine and its major active metabolite. Amphetamines increase the heart rate and blood pressure, and suppress the appetite. Some studies indicate that heavy abuse may result in permanent damage to certain essential nerve structural in the brain.



Amphetamine (AMP) Rapid Test is a competitive immunoassay that is used to screen for the presence of Amphetamine (AMP) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.


When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the test, which, regardless of its intensity, indicates a negative test result.


When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.


To serve as a procedure control, a colored line will appear at the Control Region (C) of the test, if the test has been performed properly.



  • Immunoassay for in vitro diagnostic use only.
  • Do not use after expiration date.
  • The test should remain in the sealed pouch until use.
  • The used test should be discarded according to local regulations.



  • Drug Test.
  • Desiccant
  • Leaflet with instruction for use.



  • The kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.
  • The test must remain in the sealed pouch until use.
  • Keep away from direct sunlight, moisture and heat.
  • Do not freeze.
  • Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.



Test must be in room temperature (15ºC to 30ºC)

  • Donor collects urine specimen in a urine cup.
  • Open the sealed pouch by tearing along the notch. Remove the test from the pouch and place it on a level surface.
  • Hold the sample dropper vertically, and add exactly three drops of the urine specimen into the sample well.
  • The result should be read at 5 minutes. Do not interpret the result after 10 minutes. See the illustration below.



Preliminary positive (+)

Only one colored band appears, in the control region (C). No colored band appears in the test region (T).

Negative (-)

Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).


Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.





  • The intensity of color in the test region (T) may vary depending on the concentration of analytes present in the specimen. Therefore, any shade of color in the test region should be considered negative. note that this is a qualitative test only, and cannot determine the concentration of analytes in the specimen.
  • External controls are not supplied with this kit. It is recommended that positive and negative controls be tested as a good laboratory practice to confirm the test procedure and to verify proper test performance.



1. This test has been developed for testing urine samples only. No other fluids have been evaluated. DO NOT use this device to test substances other than urine.

2. There is a possibility that technical or procedural errors, as well as interfering substances in the urine specimen may cause erroneous results.

3. Adulterated urine samples may produce erroneous results. Strong oxidizing agents such as bleach (hypochlorite) can oxidize drug analyte. If a sample is suspected of being adulterated, obtain a new sample in a different, unused, cup.

4. This test is a qualitative screening assay. It is not designed to determine the quantitative concentration of drugs or the level of intoxication.

5. A positive result does not indicate level or intoxication, administration route or concentration in urine.

6. A negative result may not necessarily indicate drug-free urine. Negative results can be obtained when drug is present but below the cut-off level of the test.



Users should follow the appropriate federal state, and local guidelines concerning the frequency of assaying external quality control materials.

Though there is an internal procedural control line in the test device of Control region, the use of external controls is strongly recommended as good laboratory testing practice to confirm the test procedure and to verify proper test performance. Positive and negative control should give the expected results. When testing the positive and negative control, the same assay procedure should be adopted.



The comparison studies were conducted using Rapid Amphetamine (AMP) Test and commercially available rapid drugs of abuse tests. The studies were performed on approximately 600 clinical specimens previous collected from the clinical settings. Presumptive positive results were confirmed by GC/MS. Results were as follows:

Test AMP
Positive Agreement 100%
Negative Agreement 99.20%
Total Agreement 99.20%


Specificity and cross reactivity

To test the specificity and cross reactivity of the test, the test device was used to test Amphetamine (AMP), metabolites and other components of the same class that are likely to be present in urine. All the components were added to drug-free normal human urine. The following structurally related compounds produced positive results with the test when tested at levels equal to or greater than the concentrations listed below.

Compound Response equivalent to cutoff in ng/mL
d-Amphetamin 1,000
d.l-Amphetamine 2,500
1-Amphetamine 50,000
(+/-) 3,4-methylenedioxyamphetamine (MDA) 2,000


Interfering substances

Clinical urine samples may contain substances that could potentially interfere with the test. The following compounds were added to drug-free urine or drug positive urine with the concentration 50% below the cutoff and 50% above the cutoff, respectively. All potential interfering substances were added at a concentration of 100µg/mL (All concentrations were confirmed with GC/MS). The urine specimens were tested with the Rapid Amphetamine (AMP) Test. None of the urine samples showed any deviation from the expected results.

Acetaminophen Chlorothiazide Estrone-3-sulfate
Acetophenetidin Chlorpheniramine Ethyl-p-aminobenzoate
Amoxicillin d,l-Chlorpromazine Erythromycin
Ampicillin Cholesterol Fenoprofen
Aspirin Clonidine Flucloxacillin
Atenolol Cimetidine Fluoxetine
Atorvastatin Citalopram Furosemide
Azlocillin Cortisone Gentisic acid
Benzilic acid Creatinine Hemoglobin
Benzylpenicillin Deoxycorticosterone Hydralazine
Benzoic acid Dexamethasone Hydrochlorothiazide
Bilirubin Dextromethorphan Hydrocortisone
Benzydamine Diclofenac o-Hydroxyhippuric acid
Caffeine Diflunisal p-Hydroxytyramine
Carbamazepine Digoxin Ibuprofen
Cephalexin Diphenhydramine Indomethacin
Chloralhydrate Ephedrine Iproniazid
Chloramphenicol β-Estradiol d,l-Isoproterenol
Isoxsuprine d,l-Octopamine Salicylic acid
Ketamine Oxalic acid Serotonin
Ketoprofen Oxolinic acid Sulfamethazine
Labetalol Oxymetazoline Sulindac
Lisinopril Oxytetracycline Tetracycline
Loperamide Papaverine Tetrahydrozoline
Meperidine Penicillin-G Thiamine
Meprobamate Pentazocine Thioridazine
Methoxyphenamine Perphenazine d, l-Thyroxine
Methylphenidate Phenelzine Tolbutamine
Nadolol Prednisolone Tolbutamide
Nalidixic acid Prednisone Trifluoperazine
Naproxen d,l-Propanolol Tryptamine
Niacinamide d-Pseudoephedrine Uric acid
Nicotine Quinacrine Verapamil
Nifedipine Quinine Zomepirac
Norethindrone Quindine  
Noscapine Ranitidine  


Effect of Urinary Specific Gravity

The specific gravity studies were conducted on different specific gravity including 1.002,1.010, 1.020, 1.030, 1.040 specimens with drug free urine or drug positive urine with the concentration at 50% below and 50% above cutoff level (All concentrations were confirmed with GC/MS). Each sample was tested by the corresponding Rapid Amphetamine (AMP) Test. The results demonstrate that varying ranges of urinary specific gravity do not affect the test result.


Effect of Urinary PH

The pH of an aliquot negative urine pool is adjusted to a pH range of 3 to 9 in 1 pH unit increments and spiked with each drug at 50% below and 50% above cutoff levels (All concentrations were confirmed with GC/MS). Each sample was tested by the corresponding Rapid Amphetamine (AMP) Test. The result demonstrate that varying ranged of PH do not interfere with the performance of the test.


Rapid Response Amphetamine (AMP) Rapid Test Kit Drug of Abuse 0

Contact Details

Phone Number : +8613316305166

WhatsApp : +8615267039708